BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25896104)

  • 1. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
    Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
    J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
    J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE; Harman S; Baughman RP
    Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
    Lower EE; Fleishman S; Cooper A; Zeldis J; Faleck H; Yu Z; Manning D
    J Pain Symptom Manage; 2009 Nov; 38(5):650-62. PubMed ID: 19896571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
    J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
    Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
    Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.
    Mar Fan HG; Clemons M; Xu W; Chemerynsky I; Breunis H; Braganza S; Tannock IF
    Support Care Cancer; 2008 Jun; 16(6):577-83. PubMed ID: 17972110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
    Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
    BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
    Spathis A; Fife K; Blackhall F; Dutton S; Bahadori R; Wharton R; O'Brien M; Stone P; Benepal T; Bates N; Wee B
    J Clin Oncol; 2014 Jun; 32(18):1882-8. PubMed ID: 24778393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.
    Minton O; Richardson A; Sharpe M; Hotopf M; Stone P
    J Natl Cancer Inst; 2008 Aug; 100(16):1155-66. PubMed ID: 18695134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
    Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
    Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
    Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
    Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR; Evans SM; Brooks DJ; Garawi F
    Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer.
    Hardy JR; Carmont SA; O'Shea A; Vora R; Schluter P; Nikles CJ; Mitchell GK
    J Palliat Med; 2010 Oct; 13(10):1193-7. PubMed ID: 20831434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
    Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
    J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.